Pierluigi is founder, Chairman and CEO at Genenta Science, a gene therapy company focused on cancer immunotherapy.
He has been founder and CEO of Quantica SGR, an Italian Venture Capital firm with 100M€ under management, and Venture Consultant for Sofinnova Partners, an European VC leader in Life Sciences with 2.6B€ under management.
He was investor and Board Member at: i) Ethical Oncology Science, acquired by Clovis Oncology (NASDAQ: CLVS), for 470M€; ii) Banzai Group, listed on Italia Stock Exchange (market cap: 250M€).
Pierluigi raised more than 140M€ from private and institutional Investors and generated more than 700M€ cash/equity in enterprise value.
He has been also Independent Member of the Research and Innovation Commission at the Italian Ministry of Health.